Neural Mechanisms of Fear in PTSD: Moving from Basic Science to Clinical Research

2012 ◽  
Author(s):  
Yuval Neria ◽  
Roger Pitman
2021 ◽  
Vol 24 ◽  
pp. 100117
Author(s):  
Matthew Carvey ◽  
Woong Kee Baek ◽  
Robert Hage

Epilepsia ◽  
2008 ◽  
Vol 49 (11) ◽  
pp. 1969-1972 ◽  
Author(s):  
Edward H. Bertram ◽  
Filiz Yilmaz Onat ◽  
Cigdem Ozkara ◽  
Solomon L. Moshé ◽  
Giuliano Avanzini

2019 ◽  
Vol 95 (1128) ◽  
pp. 524-530
Author(s):  
Mueez Waqar ◽  
Benjamin M Davies ◽  
Rasheed Zakaria ◽  
Damiano G Barone ◽  
Angelos G Kolias ◽  
...  

Academic neurosurgery encompasses basic science and clinical research efforts to better understand and treat diseases of relevance to neurosurgical practice, with the overall aim of improving treatment and outcome for patients. In this article, we provide an overview of the current and future directions of British academic neurosurgery. Training pathways are considered together with personal accounts of experiences of structured integrated clinical academic training and unstructured academic training. Life as an academic consultant is also described. Funding is explored, for the specialty as a whole and at the individual level. UK academic neurosurgical organisations are highlighted. Finally, the UK’s international standing is considered.


2016 ◽  
Vol 77 (9) ◽  
pp. 711-719 ◽  
Author(s):  
Anh Thu Nguyen-Lefebvre ◽  
Ashwin Ajith ◽  
Vera Portik-Dobos ◽  
Daniel D. Horuzsko ◽  
Laura L. Mulloy ◽  
...  

2019 ◽  
Vol 41 (4) ◽  
pp. 789-793
Author(s):  
Marco Salvetti ◽  
Mario A. Battaglia ◽  
Massimiliano Di Filippo ◽  
Gian Luigi Mancardi ◽  
Michelangelo Mancuso ◽  
...  

AbstractThe complex biology of neurological diseases calls for collaborative efforts that may increase the success rate of clinical research. Models have been proposed, but concrete actions remain insufficient. Based on recent considerations from basic science, from science of patient input and from an analysis of scientific resources in Italy, we here explain why our country may represent an appropriate environment for such actions. Furthermore, we sketch operational framework and business model to be applied in order to accelerate, in parallel, the development of therapies in common and rare diseases.


2020 ◽  
Vol 9 (8) ◽  
pp. 2373
Author(s):  
Marco Moschini

Bladder cancer (BCa) is the tenth most common form of cancer worldwide, with 549,000 new cases and 200,000 deaths estimated in 2018 [...]


Sign in / Sign up

Export Citation Format

Share Document